SENATOR GOLDEN SUPPORTS PASSAGE OF MEASURE PROTECTING NEW YORKERS FROM OVERPAYING FOR PRESCRIPTION MEDICATIONS

The New York State Senate this week gave final passage to a bill that helps fight the high cost of prescriptions by preventing consumers from overpaying for medications. This new measure (S6940) sponsored by Senator Kemp Hannon (R-Nassau), helps consumers become better informed about the price of drugs and prohibits two costly practices – gag clauses and clawbacks – used by pharmacy benefit managers (PBMs). Each have come into question recently as prescription drug prices continue to rise. 

"With the cost of prescription drugs continuing to skyrocket, this legislation is necessary to ensure people are being afforded the opportunity to pay lower drug prices when possible. Co-pays should not exceed the cost of a drug and pharmacists should be allowed to tell a consumer when the cost of a drug is in fact cheaper if they pay out of pocket. We are sending a clear message that clawbacks and pharmacy gag practices are unacceptable here in New York.”

The measure prohibits PBMs from imposing “gag clauses” in their contracts with pharmacies. Gag clauses prohibit pharmacists from telling consumers information regarding the price of medication, the availability of alternative medications, or that the drug may actually cost less if they pay out of pocket. According to the National Community Pharmacists Association, Arkansas, Connecticut, Georgia, Maine, Minnesota, Nevada, North Carolina, and North Dakota have already passed laws banning these types of gag clauses. 

This bill will also prohibit the practice of clawbacks in PBM contracts, which often result in profits generated for pharmacy benefit managers at the expense of unsuspecting customers. These clawbacks occur when a patient pays the pharmacy a copayment that is more than the actual cost of the drug. The PBM then recoups or “claws back” the excess cost collected by the pharmacy and actually makes money on the transaction. The legislation prohibits PBMs from charging a co-pay higher than the cost of the drug and prohibits them from taking additional discounts and fees from the pharmacy after the prescription has been dispensed and the claim adjudicated. 
 
The bill has passed the Assembly and will be sent to the Governor.